Literature DB >> 9182924

Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin.

W Stohl1, J E Elliott, L Li, E R Podack, D H Lynch, C O Jacob.   

Abstract

OBJECTIVE: To determine the cytolytic effector pathway involved in impaired generation of nonrestricted cytolytic activity in systemic lupus erythematosus (SLE).
METHODS: Peripheral blood mononuclear cells (PBMC) from normal subjects and SLE patients were stimulated in vitro with anti-CD3 monoclonal antibody (MAb) and interleukin-2 to promote the generation of nonrestricted cytolytic activity. On day 13 of culture, the PBMC were assayed for cytolytic activity against Fas-Daudi cells and Fas+ Jurkat cells. The effects on cytotoxicity of calcium chelation, antagonist anti-Fas MAb, tumor necrosis factor (TNF) alpha and beta, and ATP were measured. Intracellular perforin expression was determined by intracellular staining, and perforin messenger RNA levels were determined by quantitative competitive reverse transcription-polymerase chain reaction.
RESULTS: We demonstrated the existence of a cytolytic pathway that is independent of Fas, TNF alpha, TNF beta, and ATP, but is dependent upon extracellular calcium. Despite its calcium dependence, this pathway is associated with low-to-undetectable levels of perforin.
CONCLUSION: Impaired generation of nonrestricted cytolytic activity in SLE is likely due to decreased activity of this Fas-, TNF alpha-, TNF beta-, ATP-independent pathway associated with very low levels of perforin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182924     DOI: 10.1002/1529-0131(199706)40:6<1130::AID-ART17>3.0.CO;2-O

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.

Authors:  Katalin Kis-Toth; Denis Comte; Maria P Karampetsou; Vasileios C Kyttaris; Lakshmi Kannan; Cox Terhorst; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 2.  Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE.

Authors:  I Puliaeva; R Puliaev; C S Via
Journal:  Autoimmun Rev       Date:  2008-08-24       Impact factor: 9.754

3.  Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.

Authors:  A Shustov; I Luzina; P Nguyen; J C Papadimitriou; B Handwerger; K B Elkon; C S Via
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 4.  TCRzeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  Kensei Tsuzaka; Kyoko Nozaki; Chika Kumazawa; Kiyono Shiraishi; Yumiko Setoyama; Keiko Yoshimoto; Tohru Abe; Tsutomus Takeuchi
Journal:  Springer Semin Immunopathol       Date:  2006-09-05

5.  Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  M Pang; Y Setoyama; K Tsuzaka; K Yoshimoto; K Amano; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

6.  Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Clifton L Dalgard; Brian C Schaefer; Charles S Via
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

7.  Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Richard K Burt; Syamal K Datta
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  Systemic lupus erythematosus, pregnancy and carcinoma of the tongue.

Authors:  Jeffrey David Unsworth; Andrew Baldwin; Louise Byrd
Journal:  BMJ Case Rep       Date:  2013-05-31

9.  The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.

Authors:  Urszula Daniluk; Celine Kerros; Rong-Hua Tao; Jillian F Wise; Xue Ao; Zuzana Berkova; Felipe Samaniego
Journal:  J Exp Clin Cancer Res       Date:  2012-08-28

10.  Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus.

Authors:  Guo-Chang Fan; Ram Raj Singh
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.